Tuseran® Night is for cough and cold solution that provides the added benefit of uninterrupted sleep.
Tuseran® Night contains Diphenhydramine HCl and Phenylpropanolamine HCl.
Tuseran® Night is used for the relief of cough, clogged nose, runny nose, postnasal drip, sneezing, and itchy and watery eyes associated with the common cold, allergic rhinitis, sinusitis, flu and other minor respiratory tract infections. It also helps decongest sinus openings and passages.
Orally, every 6 hours, or as recommended by a doctor. Suggested dosage is 10mL or 2 tablespoons.
Tuseran® Night is available in all leading drugstores nationwide for PHP 125.00 per 60 mL bottle.
If you miss a dose, just take the next dose if still needed for the condition being treated, and the subsequent doses at the recommended time or schedule (i.e., every 6 hours). Do not double the dose.
If you have taken more than the recommended dosage, consult a doctor or contact a poison control center right away, even if you seem well, because of the risk of delayed, serious liver damage. Quick medical attention is important for adults as well as for children even if you do not notice any signs or symptoms.
Diphenhydramine may cause sedation, dizziness, tinnitus (ringing in the ears), fatigue (excessive tiredness), ataxia (lack of muscle coordination), blurred vision, diplopia (double vision), euphoria (feeling of great happiness or well-being), nervousness, and tremors (muscle shaking). Gastrointestinal effects include epigastric distress, nausea and vomiting, which may be reduced by taking diphenhydramine with meals. Other side effects include dryness of mouth and mucous secretions, palpitation (rapid and irregular heart beat), urinary tract dysfunction, and severe allergic reactions such as difficulty of breathing and swelling of the face, neck, tongue or throat.
Phenypropanolamine may cause sudden, persistent, severe headache, nervousness, restlessness, insomnia/sleeplessness, dizziness, anxiety (feeling of uneasiness), confusion, high blood pressure, palpitation, chest tightness, tremor, agitation, irritability, aggressiveness (particularly in young children), nausea, and blurred vision.
Do not use this product together with alcohol, medicines for anxiety or sleep disorder (e.g. alprazolam, chlordiazepoxide, diazepam, temazepam, triazolam, etc.), medicines for depression (e.g. amitriptyline, imipramine, moclobemide, sertraline, etc.), other cold or allergy medicines, or any other medicines that cause drowsiness, sleepiness and relaxation because of the possibility for increased sedation.
Concurrent administration with monoamine oxidase inhibitors (MAOIs; e.g. , phenelzine, selegiline, etc.) may result in hypertensive crisis (sudden, severe increase in blood pressure that can lead to stroke). Do not use this product in patients taking MAOIs or within two weeks after stopping a MAOI.
Do not use this product together with sympathomimetic agents (e.g., epinephrine, etc.) and general anesthetics (e.g., halothane, etc.) because of the possibility for increased toxicity. Do not use this product with beta-blockers (e.g., carvedilol, metoprolol, propranolol) as diphenhydramine may increase the amount of beta-blockers in the blood which may result in increased cardiovascular effects of these medicines.
Tell your doctor about other medicines you are taking (i.e., other medicines for cough, cold or allergy).
Mild cases of diphenhydramine overdoses are mainly characterized by dry mouth, headache, nausea, tachycardia (fast heart rate), and urinary retention.
In children, the clinical features include hallucinations, dilated pupils, fever, ataxia, and convulsions. Cardiorespiratory depression and coma may subsequently develop, with death occurring between 2 to 18 hours. Adults usually develop drowsiness first, then convulsion, and coma at a later stage.
Signs and symptoms of phenylpropanolamine overdose include tachycardia, arrhythmia (irregular heartbeat), high blood pressure, excitation, enlargement of the pupils. Case of heart attack, stroke, intracranial hemorrhage/cerebral hemorrhage (bleeding from a ruptured blood vessel in the brain), seizures, and death have also been reported.